Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
Nigeria
Politics
Crime
Premier League
Economy
Africa
World
Entertainment
Sport
La Liga
Serie A
Bundesliga
Lifestyle
Bitcoin
Cryptocurrencies
Sensational News

"Ultragenyx"
Topics

Advertisement

Advertisement

"Ultragenyx"

Showing articles that match "Ultragenyx" in the headline

Sunday

Is Ultragenyx Pharmaceutical (RARE) Cheap On FAYUVI FDA Approval? Simply Wall St 15:00 Sun, 20 Sep

Friday

Ultragenyx gets rare win with FDA nod for Sanfilippo gene therapy BioWorld 21:28 Fri, 18 Sep

Ultragenyx Turns To Launch Execution After Long Road For Sanfilippo Gene Therapy Scrip Pharma Intelligence 16:59 Fri, 18 Sep

Advertisement

Advertisement

Ultragenyx Wins First Sanfilippo Approval As Analyst Keeps Ratings Modest Benzinga 14:25 Fri, 18 Sep

Andelyn and Its Curator® Platform Achieve First FDA-Approved Commercial Gene Therapy Manufacturing Milestone Following FDA Approval of Ultragenyx's FAYUVI™ to Treat Sanfilippo Syndrome Type A (MPS IIIA) Newswise (Press Release) 14:18 Fri, 18 Sep

Ultragenyx (RARE) Surges 12.6%: Is This an Indication of Further Gains? Zacks 13:33 Fri, 18 Sep

Andelyn and Its Curator® Platform Achieve First FDA-Approved Commercial Gene Therapy Manufacturing Milestone Following FDA Approval of Ultragenyx's Fayuvitm to Treat Sanfilippo Syndrome Type A (Mps Iiia) PR Newswire (Press Release) 13:09 Fri, 18 Sep

Abeona Stands to Collect Royalties After Ultragenyx's FDA Approval — Here's the Rest of the Week Benzinga 12:54 Fri, 18 Sep

Ultragenyx gets FDA nod for first Sanfilippo A gene therapy pharmaphorum 10:47 Fri, 18 Sep

Ultragenyx Pharmaceutical (rare) Stock Jumps After Hours: Here's Why It Is Trending Benzinga 05:37 Fri, 18 Sep

Is Ultragenyx Pharmaceutical (RARE) Reasonable After Its FDA Gene Therapy Approval? Simply Wall St 02:58 Fri, 18 Sep

Thursday

Ultragenyx wins FDA nod for Sanfilippo gene therapy BioWorld 21:10 Thu, 17 Sep

Investor alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - Rare PR Newswire (Press Release) 15:01 Thu, 17 Sep

In the last month

Why Ultragenyx Pharmaceutical (RARE) Is Down 40.3% After Aspire Trial Failure And Expense Cut Plans Simply Wall St 21:22 Sat, 05 Sep

Ultragenyx mulls fate of rare disease programme on Phase III flop Clinical Trials Arena 09:34 Fri, 04 Sep

Angelman wings clipped by Ultragenyx phase III bust BioWorld 21:29 Thu, 03 Sep

Quick spark: Pharma Bro Martin Shkreli Says Ultragenyx Should Be M&A Target Benzinga 17:20 Thu, 03 Sep

Ultragenyx to slash costs after Angelman trial failure pharmaphorum 14:34 Thu, 03 Sep

Advertisement

STAT Plus: We’re reading about an Ultragenyx failure, RevMed for lung cancer, and more STAT 14:26 Thu, 03 Sep

Ultragenyx Forced To Cut Costs After Disappointing Phase 3 Results Benzinga 14:17 Thu, 03 Sep

Ultragenyx’s Angelman Syndrome Failure Raises Big Questions About Its Pipeline Scrip Pharma Intelligence 12:05 Thu, 03 Sep

STAT Plus: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial STAT 21:44 Wed, 02 Sep

Ultragenyx FDA-Approved Treatment Shows Sustained Reduction in Cornstarch Intake Benzinga 15:44 Wed, 02 Sep

FDA Approves Ultragenyx’s GENGLYCOS™ Gene Therapy for GSDIa JD Supra 20:54 Mon, 31 Aug

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Nigeria Nigeria
Politics Politics
Crime Crime
Premier League
Economy Economy
Africa Africa
World World
Entertainment
Sport Sport
La Liga La Liga
Serie A Serie A
Bundesliga Bundesliga
Lifestyle Lifestyle
Bitcoin Bitcoin
Cryptocurrencies
Sensational News